NASDAQ:LEGN
Legend Biotech
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.legendbiotech.comipo date
Jun 05, 2020
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM), as well as a comp...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus